Review article: Nuclear receptors and liver disease - Current understanding and new therapeutic implications

D. A H Elfaki, E. Bjornsson, Keith Lindor

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

SummaryBackground The important role of nuclear receptors and their contribution to liver function in both physiological and pathological conditions has come to attention in recent years and has advanced our understanding of several liver diseases. These findings led to the introduction of targeting nuclear receptors as treatment strategies for various liver diseases. Aims To review the new insights brought by the study of nuclear receptors to our understanding of the molecular basis of various liver diseases, and to summarize some of the recent studies that evaluated the efficacy of targeting nuclear receptor as a new approach in treating liver diseases. Methods Review of articles, using PubMed and article references. Results Nuclear receptor ligands in patients with liver diseases have been associated with a variety of toxicities. Some clinical results have not met the expectations predicted from animal experiments. Mechanistic explanations at the molecular level are needed for preventing toxicity and improving outcomes from nuclear receptor ligands. Conclusion The use of various nuclear receptor ligands in liver diseases is a promising approach that can benefit many patients suffering from these devastating diseases. However, we are far from a full understanding of the molecular mechanisms by which these receptors work.

Original languageEnglish (US)
Pages (from-to)816-825
Number of pages10
JournalAlimentary Pharmacology and Therapeutics
Volume30
Issue number8
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Cytoplasmic and Nuclear Receptors
Liver Diseases
Ligands
Therapeutics
PubMed
Liver

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Review article : Nuclear receptors and liver disease - Current understanding and new therapeutic implications. / Elfaki, D. A H; Bjornsson, E.; Lindor, Keith.

In: Alimentary Pharmacology and Therapeutics, Vol. 30, No. 8, 10.2009, p. 816-825.

Research output: Contribution to journalArticle

@article{6e6157c72ee7499e8da4b385d6138947,
title = "Review article: Nuclear receptors and liver disease - Current understanding and new therapeutic implications",
abstract = "SummaryBackground The important role of nuclear receptors and their contribution to liver function in both physiological and pathological conditions has come to attention in recent years and has advanced our understanding of several liver diseases. These findings led to the introduction of targeting nuclear receptors as treatment strategies for various liver diseases. Aims To review the new insights brought by the study of nuclear receptors to our understanding of the molecular basis of various liver diseases, and to summarize some of the recent studies that evaluated the efficacy of targeting nuclear receptor as a new approach in treating liver diseases. Methods Review of articles, using PubMed and article references. Results Nuclear receptor ligands in patients with liver diseases have been associated with a variety of toxicities. Some clinical results have not met the expectations predicted from animal experiments. Mechanistic explanations at the molecular level are needed for preventing toxicity and improving outcomes from nuclear receptor ligands. Conclusion The use of various nuclear receptor ligands in liver diseases is a promising approach that can benefit many patients suffering from these devastating diseases. However, we are far from a full understanding of the molecular mechanisms by which these receptors work.",
author = "Elfaki, {D. A H} and E. Bjornsson and Keith Lindor",
year = "2009",
month = "10",
doi = "10.1111/j.1365-2036.2009.04104.x",
language = "English (US)",
volume = "30",
pages = "816--825",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Review article

T2 - Nuclear receptors and liver disease - Current understanding and new therapeutic implications

AU - Elfaki, D. A H

AU - Bjornsson, E.

AU - Lindor, Keith

PY - 2009/10

Y1 - 2009/10

N2 - SummaryBackground The important role of nuclear receptors and their contribution to liver function in both physiological and pathological conditions has come to attention in recent years and has advanced our understanding of several liver diseases. These findings led to the introduction of targeting nuclear receptors as treatment strategies for various liver diseases. Aims To review the new insights brought by the study of nuclear receptors to our understanding of the molecular basis of various liver diseases, and to summarize some of the recent studies that evaluated the efficacy of targeting nuclear receptor as a new approach in treating liver diseases. Methods Review of articles, using PubMed and article references. Results Nuclear receptor ligands in patients with liver diseases have been associated with a variety of toxicities. Some clinical results have not met the expectations predicted from animal experiments. Mechanistic explanations at the molecular level are needed for preventing toxicity and improving outcomes from nuclear receptor ligands. Conclusion The use of various nuclear receptor ligands in liver diseases is a promising approach that can benefit many patients suffering from these devastating diseases. However, we are far from a full understanding of the molecular mechanisms by which these receptors work.

AB - SummaryBackground The important role of nuclear receptors and their contribution to liver function in both physiological and pathological conditions has come to attention in recent years and has advanced our understanding of several liver diseases. These findings led to the introduction of targeting nuclear receptors as treatment strategies for various liver diseases. Aims To review the new insights brought by the study of nuclear receptors to our understanding of the molecular basis of various liver diseases, and to summarize some of the recent studies that evaluated the efficacy of targeting nuclear receptor as a new approach in treating liver diseases. Methods Review of articles, using PubMed and article references. Results Nuclear receptor ligands in patients with liver diseases have been associated with a variety of toxicities. Some clinical results have not met the expectations predicted from animal experiments. Mechanistic explanations at the molecular level are needed for preventing toxicity and improving outcomes from nuclear receptor ligands. Conclusion The use of various nuclear receptor ligands in liver diseases is a promising approach that can benefit many patients suffering from these devastating diseases. However, we are far from a full understanding of the molecular mechanisms by which these receptors work.

UR - http://www.scopus.com/inward/record.url?scp=70349421143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349421143&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2009.04104.x

DO - 10.1111/j.1365-2036.2009.04104.x

M3 - Article

C2 - 19706148

AN - SCOPUS:70349421143

VL - 30

SP - 816

EP - 825

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 8

ER -